Teva (TEVA) enters into a JV with South Korea's Handok Pharmaceuticals to sell the Israel...

|About: Teva Pharmaceutical Indus... (TEVA)|By:, SA News Editor

Teva (TEVA) enters into a JV with South Korea's Handok Pharmaceuticals to sell the Israel company's drugs in the country, where the market is worth $14B and where healthcare spending is expected to hit 9% of GDP within three years. The move fits in with Teva's new strategy, which includes expanding its global presence and carrying out more business development. (PR)